Live from the NIH registry
Studies recruiting near Milwaukee right now
Top 25 of 698 recruiting studies, sorted by proximity — each links to its official registry page
CIBMTR Research Database
Autologous Stem Cell Transplantation, Allogeneic Stem Cell Transplantation
N/A
Observational 99,999,999 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Center for International Blood and Marrow Transplant Research
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Aurora Cancer Care - Milwaukee West — Wauwatosa, Wisconsin (2.3 mi)
· Sponsor: American Society of Clinical Oncology
External UES Band (Shaker Pressure Band) and GERD
Gastroesophageal Reflux
N/A
Interventional 350 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer
Advanced Solid Tumor, High Grade Serous Adenocarcinoma of Ovary
Phase 1, Phase 2
Interventional 200 participants sought
Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Volastra Therapeutics, Inc.
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Non Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma
Phase 1
Interventional 12 participants sought
Froedtert & the Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: National Cancer Institute (NCI)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Medical College of Wisconsin ( Site 0103) — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
MCW-Clinical Cancer Center at Froedtert Hospital Campus — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: C4 Therapeutics, Inc.
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Ascension Medical Group Southeast Wisconsin - Mayfair Road — Wauwatosa, Wisconsin (2.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
Migraine
Phase 2
Interventional 488 participants sought
The Mind+ Neurology Clinic — Mequon, Wisconsin (10.9 mi)
· Sponsor: AbbVie
A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib
Chronic Lymphocytic Leukemia, Non-Hodgkin Lymphoma
Phase 4
Interventional 787 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Eli Lilly and Company
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Sameek Roychowdhury
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Acute Myeloid Leukemia (AML)
Phase 3
Interventional 1,300 participants sought
Froedtert & Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Kura Oncology, Inc.
A Study of BG-75098 Alone and in Combination With Other Agents in Adults With Advanced Solid Tumors
Advanced Solid Tumor
Phase 1
Interventional 105 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: BeOne Medicines
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Annovis Bio Inc.
Study to Enable New Diagnostics for Pulmonary Microbes in People With CF
Cystic Fibrosis (CF), New Diagnostics
N/A
Observational 300 participants sought
Froedtert & Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Chris Goss
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Pulmonary Invasive Fungal Infections, Pulmonary Invasive Aspergillosis
N/A
Observational 400 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Arkansas Children's Hospital Research Institute
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Aurora Cancer Care-Milwaukee West — Wauwatosa, Wisconsin (2.3 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Striated Esophageal Motor Function Modulation in Health and Disease
Dysphagia, Esophageal
N/A
Interventional 557 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED
Persistent Corneal Epithelial Defect
Phase 2
Interventional 84 participants sought
Glaukos Investigative Site — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Glaukos Corporation
E-Mindfulness Approaches for Living After Breast Cancer
Breast Cancer, Depression
Phase 3
Interventional 402 participants sought
UW Cancer Center at ProHealth Care — Waukesha, Wisconsin (13.8 mi)
· Sponsor: NRG Oncology
Early Versus Late Endoscopic Stenting for Refractory Benign Esophageal Strictures
Refractory Benign Esophageal Strictures
N/A
Interventional 20 participants sought
Froedtert Hospital — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Medical College of Wisconsin
Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
COPD, Chronic Obstructive Pulmonary Disease
N/A
Interventional 200 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Nuvaira, Inc.
Postpartum Exercise Intervention
Postpartum, Neuromuscular Adaptations
N/A
Interventional 50 participants sought
Carroll University Center for Graduate Studies — Waukesha, Wisconsin (13.8 mi)
· Sponsor: Carroll University
Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs
Failed or Difficult Intubation, Sequela, Intubation; Difficult
N/A
Observational 150,000 participants sought
Medical College of Wisconsin — Milwaukee, Wisconsin (3.5 mi)
· Sponsor: Children's Hospital of Philadelphia